FDA Recommends Clinical Trial Sponsors Consider Virtual Visits
VirTrial
APRIL 29, 2020
The FDA recently released new guidance on clinical trials in the face of COVID-19. In their published report, FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic , they acknowledged that challenges may arise in ongoing trials. For example, quarantines, site closures, travel limitations, etc. may lead to difficulties in meeting protocol-specified procedures including administering or using the investigational product or adhering to protocol-mandated visits and
Let's personalize your content